1. Home
  2. TECH vs GTLB Comparison

TECH vs GTLB Comparison

Compare TECH & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • GTLB
  • Stock Information
  • Founded
  • TECH 1976
  • GTLB 2011
  • Country
  • TECH United States
  • GTLB United States
  • Employees
  • TECH N/A
  • GTLB N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • GTLB EDP Services
  • Sector
  • TECH Health Care
  • GTLB Technology
  • Exchange
  • TECH Nasdaq
  • GTLB Nasdaq
  • Market Cap
  • TECH 7.8B
  • GTLB 7.5B
  • IPO Year
  • TECH 1989
  • GTLB 2021
  • Fundamental
  • Price
  • TECH $53.94
  • GTLB $42.03
  • Analyst Decision
  • TECH Buy
  • GTLB Buy
  • Analyst Count
  • TECH 12
  • GTLB 25
  • Target Price
  • TECH $70.00
  • GTLB $64.52
  • AVG Volume (30 Days)
  • TECH 1.9M
  • GTLB 4.9M
  • Earning Date
  • TECH 08-06-2025
  • GTLB 09-02-2025
  • Dividend Yield
  • TECH 0.59%
  • GTLB N/A
  • EPS Growth
  • TECH N/A
  • GTLB N/A
  • EPS
  • TECH 0.83
  • GTLB 0.08
  • Revenue
  • TECH $1,208,770,000.00
  • GTLB $804,571,000.00
  • Revenue This Year
  • TECH $7.07
  • GTLB $26.39
  • Revenue Next Year
  • TECH $5.72
  • GTLB $21.30
  • P/E Ratio
  • TECH $65.29
  • GTLB $523.00
  • Revenue Growth
  • TECH 4.72
  • GTLB 29.31
  • 52 Week Low
  • TECH $46.01
  • GTLB $37.90
  • 52 Week High
  • TECH $83.62
  • GTLB $74.18
  • Technical
  • Relative Strength Index (RSI)
  • TECH 59.94
  • GTLB 38.17
  • Support Level
  • TECH $50.97
  • GTLB $45.10
  • Resistance Level
  • TECH $55.53
  • GTLB $47.13
  • Average True Range (ATR)
  • TECH 2.07
  • GTLB 1.74
  • MACD
  • TECH 0.24
  • GTLB 0.13
  • Stochastic Oscillator
  • TECH 77.60
  • GTLB 27.94

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About GTLB GitLab Inc.

GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.

Share on Social Networks: